Cariprazine: Patients with Treatment-Resistant Schizophrenia
Author:
Publisher
Informa UK Limited
Reference24 articles.
1. Schizophrenia
2. Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist–Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile
3. Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO
4. Cariprazine in the treatment of schizophrenia
5. An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: A phase II, randomized clinical trial
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cariprazine in the management of emotionally unstable personality disorder in female patients: a case series;Frontiers in Psychiatry;2024-07-08
2. A review on the pharmacology of cariprazine and its role in the treatment of negative symptoms of schizophrenia;Frontiers in Psychiatry;2024-04-22
3. Cariprazine augmentation of clozapine in schizophrenia—a retrospective chart review;Frontiers in Pharmacology;2024-01-04
4. Cariprazine Augmentation in Inadequate Clozapine Response: A Case Series;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2024
5. The phenomenon of therapeutic resistance in the treatment of schizophrenia: the possibilities of modern diagnostics and methods of anti-resistant effects;V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY;2023-12-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3